COHANCE: USFDA INSPECTION OF ITS FORMULATION PLANT AT SHAMSHABAD, TELANGANA CONCLUDED WITH FOUR OBSERVATIONS

• The inspection took place from 27 August to 4 September 2026. • The company has initiated corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. • Cohance remains committed to quality and regulatory compliance. Impact: Neutral (Routine regulatory filing regarding an inspection with standard observations and response initiation.)

Cohance Lifesciences Limited

Open attachment

← Back to feed